Tag Archives: bad-request

Regeneron, Amgen Downgraded As Biotech Seen Slowing

UBS downgraded Regeneron (REGN) and Amgen (AMGN) and adjusted the price targets on several other biotech stocks Thursday on the grounds that the sector may be in for a slow patch. “Although we still think that biotech will continue to outperform the broader markets and the Health Care SPDR (XLV), we are getting more selective with our price targets and ratings considering fewer near-term catalysts with the power to drive material upward revisions

T-Mobile Q2 Subscriber Adds Strong, Targets AT&T

T-Mobile US (TMUS) early Thursday preannounced strong Q2 subscriber numbers and unveiled its newest Uncarrier-branded promotion — offering customers free roaming to Mexico and Canada — sending its stock up. In Q2, T-Mobile said it added 2.1 million net subscribers, up 41% from the year-earlier period, including 760,000 postpaid phone subscribers , up 31%. Including 248,000 postpaid mobile broadband accounts, mostly tablet users, postpaid

Insys And Mobileye Earn The Best Of Best Fundamentals

Companies putting up unusually strong fundamental growth numbers are good candidates for a stock watch list. Today’s Screen Of The Day is Top Fundamentals, featuring highly rated firms with three-year sales and earnings growth rates of at least 25%, averaged over the three-year period, sorted by the biggest estimated earnings growth rate of the past year. Two companies on the list, Insys Therapeutics and Mobileye, stand out because they lead the